|
|
Conference:
Pre-conference workshop
1 Dec 9am - 5pm
Day 1
2 Dec 8.30am - 5:30pm
Day 2
3 Dec 8.30am - 5:30pm
Post-conference workshop
4 Dec 8.30am - 5:30pm
Venue:
The Bloomsbury Hotel, London, United Kingdom
› Email a friend
› Add this to my calendar
|
|
|
 Dr Peter Kolominsky-Rabas,
Former Head of Department IQWiG, Germany Priv.-Doz. Dr. Kolominsky-Rabas is the Managing Director of the Interdisciplinary Centre for Health Technology Assessment and Public Health, University of Erlangen-Nuremberg, Bavaria, Germany. Dr. Kolominsky-Rabas received his M.D. degree �summa cum laude� from the University of Muenster and his Ph.D. in �Epidemiology and Outcomes Research� from the University of Erlangen in 2003, where he completed his clinical training in the Departments of Neurology, Neuroradiology, Psychiatry and Rehabilitation. He received his M.B.A. from the University of Bayreuth and is Senior Lecturer in Public Health and Outcomes Research at University of Erlangen since 2003. Dr. Kolominsky-Rabas established the community-based Erlangen Stroke Register (ESR) in 1994, which is the designated reporting centre for the Federal Health Monitoring for cerebrovascular diseases to the German government. His research interests are in the field of health outcomes research, health economics and management. From 2005-2008 Dr. Kolominsky-Rabas was Head of Department �Health Economics and Outcomes Research� in the Institute for Quality and Efficiency in Health Care (IQWiG) in Cologne, which is the main scientific advisory body to the Federal Government and the Federal Joint Committee (GBA) representing the German Statutory Health Insurance System. During this time Dr. Kolominsky-Rabas was deeply involved in shaping the HTA conception for the German health care system and all strategic matters.Appearing: Day One - Wednesday 2 December 2009 16.15 HTA expectations in late phase development – IQWiG update
- Use of evidence based information in the decision making process
- IQWiG recommendations and role out
- Method development impacting HTA in Germany
Former Head of Department,
IQWiG, Germany |
|
|
|
|
Dr Ellen Strahlman
Chief Medical Officer
GlaxoSmithKline
Dr Clive Morris
Medical Science Director
AstraZeneca
Mark Latymer
Scientific Advisor
Pfizer
Amy Sing
Associate Group Director - Post Marketing
Genentech
Professor Markus Kosch
Associate Medical Director
Wyeth Pharma
|
|
|
|
|
|
|
|
|
